FDAnews
www.fdanews.com/articles/145562-abbott-8217-s-humira-set-to-become-world-8217-s-top-selling-drug

Abbott’s Humira Set to Become World’s Top-Selling Drug

April 11, 2012
Abbott Laboratories’ $9-billion arthritis drug Humira is set to take the crown as the world’s top-selling medicine this year, highlighting the dominance of costly biotechnology products as revenues from old-style pills decline.
Chicago Tribune